Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).

Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology). - 2022

Available online from MWHC library: 1997 - present


English

0167-6806

10.1007/s10549-022-06613-4 [doi] 10.1007/s10549-022-06613-4 [pii]


Associate Dean for Research Development
MedStar Health


Published Erratum

Powered by Koha